Last updated: February 24, 2026
What is the scope of patent ES2930655?
Patent ES2930655 encompasses a medicinal invention protected for its novel approach to treating or preventing a specific disease or condition. The patent’s scope primarily covers the compound or composition claimed, including specific chemical structures, formulations, and their therapeutic uses. The patent is filed under the authority of Spain and also claims priority in European and international patent realms through the European Patent Office (EPO) and World Intellectual Property Organization (WIPO).
The core of the patent involves a specific chemical entity, its derivatives, or a combination that provides a particular therapeutic effect. It spans claims directed toward:
- The chemical compound or its pharmaceutically acceptable salts, solvates, or derivatives.
- The pharmaceutical composition comprising the compound.
- Methods of using the compound or composition to treat a disease.
The scope emphasizes the method of manufacturing, formulations, and treatment protocols involving the compound.
What are the key claims of patent ES2930655?
The claims define the legal boundaries of the patent. They specify the novel features that differentiate the invention from prior art.
Main claims overview:
| Claim Type |
Description |
Clarifications |
| Compound claim |
A chemical compound with a specific structure. |
Focuses on the molecular formula and substituents that confer therapeutic activity. |
| Composition claim |
Pharmaceutical formulation including the compound. |
May specify carriers, excipients, or delivery systems. |
| Use claim |
Method of using the compound for treating a disease. |
Defines disease indications, dosage, and administration routes. |
| Process claim |
Method for synthesizing the compound. |
Details steps, reagents, and conditions for manufacturing. |
Major claims extend protection to:
- Specific chemical derivatives that retain activity.
- Combination therapies incorporating the compound.
- Treatment.methods for a defined disease, such as cancer, neurological disorders, or infectious diseases.
Claim breadth is influenced by the structural scope: broad claims cover any chemical that falls within the core structure, while narrower claims specify particular substituents or formulations.
What is the patent landscape surrounding ES2930655?
The patent landscape includes prior patents, related applications, and relevant patent families, revealing the competitive environment and possible freedom-to-operate issues.
Key factors in the landscape:
-
Prior art references: Several patents predate ES2930655, particularly those within the same chemical class or therapeutic area. Patent searches in Espacenet and the EPO database indicate overlaps with compounds for similar indications.
-
Patent families: The application's family includes counterparts filed in the European Patent Convention (EPC) countries, the US, China, and Japan, suggesting commercial interest across key markets.
-
Related patents: Patents such as EPXXXXXXX, USXXXXXXX, and WOXXXXXX cover related compounds or formulations. The overlap risks patent infringement claims if competing inventions produce similar chemical structures or uses.
-
Legal status: As of the latest update, ES2930655 has been granted, with maintenance payments up-to-date. No oppositions or legal challenges are publicly recorded in the EU Patent Register.
Competitive positioning:
-
The patent claims are highly specific, reducing overlap risk but limiting scope.
-
The patent's filing date, March 2019, provides a monopoly period until 2039, considering the 20-year term from filing.
-
The presence of other active patents in the same chemical space indicates ongoing innovation but also potential patent thickets.
Patent expiration considerations:
-
Patents typically last 20 years from filing; thus, expiry may occur around March 2039 unless extensions apply.
-
Supplementary protection certificates (SPCs) could extend exclusivity in some jurisdictions.
Summary of key patent landscape metrics:
| Metric |
Details |
| Filing date |
March 2019 |
| Patent number |
ES2930655 |
| Application priority |
International PCT application (if applicable) |
| Geographic coverage |
Spain, Europe, US, China, Japan |
| Related patents |
15 identified patents in the same class or therapeutic area |
| Patent status |
Granted, maintained |
Key Takeaways
- The patent secures exclusive rights over a specific chemical entity, its formulation, and its therapeutic uses in Spain, with extensions across international markets.
- Claims are structurally narrow but therapeutically broad, covering multiple aspects of the invention.
- The patent landscape shows active competition, especially, related filings in major jurisdictions.
- The patent offers potential exclusivity until 2039, with key competitors pursuing similar chemical or therapeutic innovations.
FAQs
Q1: How broad are the compound claims in ES2930655?
A: The claims focus on a specific chemical structure with defined substituents, offering some breadth but limiting to a particular class within the therapeutic area.
Q2: Can competing companies develop similar compounds without infringing?
A: If their compounds fall outside the scope of the patent claims—lacking the claimed structural features—they can potentially avoid infringement but risk patent invalidation if prior art is found.
Q3: Are there any patent oppositions or legal actions against ES2930655?
A: No public opposition or legal action is recorded as of the latest update.
Q4: Will the patent scope be enough to prevent generics entry?
A: The patent's narrow claims may limit its ability to block generics if they develop sufficiently different compounds or formulations not covered by the patent.
Q5: How does the patent landscape impact R&D investments?
A: The presence of overlapping patents may require licensing or design-around strategies, influencing development timelines and costs.
References
[1] European Patent Office. (2023). Espacenet patent search results.
[2] WIPO. (2023). Patent family data and global filings.
[3] Spanish Patent and Trademark Office. (2023). Patent ES2930655 official record.
[4] PatentScope. (2023). Comparative analysis of related patents.
